<DOC>
	<DOCNO>NCT01328132</DOCNO>
	<brief_summary>The primary aim study assess effect hyperoncotic albumin vascular hemodynamics oxygen delivery orthotopic liver transplant . The secondary aim try identify dominant physiological mechanism able good identify patient may benefit use albumin ( 25 % ) boluses addition standard care patient follow liver transplantation .</brief_summary>
	<brief_title>Effect Hyperoncotic Albumin Vascular Hemodynamics Oxygen Delivery Following Orthotopic Liver Transplant</brief_title>
	<detailed_description />
	<criteria>18 year old Patients Critical care Unit Patients pulmonary artery occlusion catheter Inclusion : patient immediately follow liver transplantation Patients give informed consent Patients receive &gt; 300 ml albumin within 24 hour prior inclusion Patients know previous adverse reaction human albumin solution Patients religious restriction receive human blood product Patient initial graft failure Patients fluctuate hemodynamics Concerns treat surgeon</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Liver</keyword>
	<keyword>transplant</keyword>
	<keyword>albumin</keyword>
</DOC>